NCT05920655

Brief Summary

The aim of this study is to investigate the early changes in macular thickness, corneal thickness and intraocular pressure in young women undergoing surgical menopause. Methods: Eye findings of 30 surgical menopausal (Postoperative 3-6 months) and 48 natural menopause and 22 healty women (control) were evaluated using OCT. Women with no known eye disease, no chronic disease (Diabetes Mellitus, Cardiac Disease any Autoimmune disease) and no migraine in addition to non smokers were included in the study. Women using any hormone and obese women ( BMI \>25 kg/m2) were excluded. Macular and corneal thickness and intraocular pressure (IOP) were measured in both eyes of the women

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 12, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 17, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
Last Updated

June 27, 2023

Status Verified

June 1, 2023

Enrollment Period

1.3 years

First QC Date

June 17, 2023

Last Update Submit

June 17, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effect of surgical menopause on corneal and macular thickness

    To question the effect on macular and corneal thickness secondary to sudden ovarian hormone change with surgical menopause.

    6 months after hysterectomy and bilateral salpingo-oopherectomy

Secondary Outcomes (1)

  • Eye examination needed after surgical menopause

    6-12 months

Study Arms (3)

1( Surgical menopause)

Surgical menopause : At least 6 months after hysterectomy and salphingo-oopherectomy

Diagnostic Test: Optic coherence tomography

2 ( Natural menopause )

Natural menopause :Healthy female patients who have not had a menstrual period for at least 1 year and have not received any treatment for this reason before

Diagnostic Test: Optic coherence tomography

3 (Control )

Healthy women aged 30-45 years with regular menstrual cycles and no symptoms of menopause

Diagnostic Test: Optic coherence tomography

Interventions

Eye examination of patients with optic coherence tomography test by an ophthalmologist

1( Surgical menopause)2 ( Natural menopause )3 (Control )

Eligibility Criteria

Age30 Years - 55 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale ,age between 30-55 .
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patient selection was made between surgical menopause, natural menopause and healthy women who have given birth before.

You may qualify if:

  • The patients included in the study were menstruating women with preoperative natural ovarian appearance and benign non ovarian indications, who had undergone hysterectomy and bilateral salpingo-oopherectomy, and had no preoperative menopause complaints. Patients younger than 52 years of age who have undergone oophorectomy are patients whose ovaries have been removed either because of patient anxiety due to a family history of cancer or because of adhesions.
  • having a healthy child
  • have consented to participate in the study

You may not qualify if:

  • Chronic disease (such as diabetes, heart disease)
  • History of continuous drug use
  • Unwillingness to participate in the study Being between the ages of 18-30

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Batman education adn research hospital

Batman, 72100, Turkey (Türkiye)

Location

Study Officials

  • Erhan Okuyan

    Batman Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D

Study Record Dates

First Submitted

June 17, 2023

First Posted

June 27, 2023

Study Start

February 12, 2022

Primary Completion

June 1, 2023

Study Completion

June 15, 2023

Last Updated

June 27, 2023

Record last verified: 2023-06

Locations